feed,title,long_url,short_url
SeekingAlpha,Regenxbio begins phase 1/2 trial of Duchenne muscular dystrophy candidate,https://seekingalpha.com/news/3926752,
SeekingAlpha,RingCentral shares rise 2% despite MKM rating cut,https://seekingalpha.com/news/3926751,
